XML 25 R55.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information (Tables)
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Revenue by product
 
For the Years Ended December 31,
 
2014
 
2013
 
2012
(In millions)
United
States
 
Rest of
World
 
Total
 
United
States
 
Rest of
World
 
Total
 
United
States
 
Rest of
World
 
Total
Multiple Sclerosis (MS):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AVONEX
$
1,956.7

 
$
1,056.4

 
$
3,013.1

 
$
1,902.4

 
$
1,103.1

 
$
3,005.5

 
$
1,793.7

 
$
1,119.4

 
$
2,913.1

PLEGRIDY
27.8

 
16.7

 
44.5

 

 

 

 

 

 

TECFIDERA
2,426.6

 
482.6

 
2,909.2

 
864.4

 
11.7

 
876.1

 

 

 

TYSABRI
1,025.1

 
934.4

 
1,959.5

 
814.2

 
712.3

 
1,526.5

 
383.1

 
752.8

 
1,135.9

FAMPYRA

 
80.2

 
80.2

 

 
74.0

 
74.0

 

 
57.4

 
57.4

Hemophilia:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ALPROLIX
72.1

 
3.9

 
76.0

 

 

 

 

 

 

ELOCTATE
58.4

 

 
58.4

 

 

 

 

 

 

Other product revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FUMADERM

 
62.5

 
62.5

 

 
60.2

 
60.2

 

 
59.7

 
59.7

Total product revenues
$
5,566.7

 
$
2,636.7

 
$
8,203.4

 
$
3,581.0

 
$
1,961.3

 
$
5,542.3

 
$
2,176.8

 
$
1,989.3

 
$
4,166.1

Geographic information
December 31, 2014 (In millions)
U.S.
 
Europe(1)
 
Germany
 
Asia
 
Other
 
Total
Product revenues from external customers
$
5,566.7

 
$
1,383.9

 
$
811.8

 
$
112.8

 
$
328.2

 
$
8,203.4

Revenues from unconsolidated joint business
$
1,117.1

 
$
7.7

 
$

 
$

 
$
70.6

 
$
1,195.4

Other revenues from external customers
$
212.6

 
$
31.6

 
$
1.8

 
$
58.5

 
$

 
$
304.5

Long-lived assets
$
1,055.5

 
$
701.9

 
$
2.5

 
$
2.6

 
$
3.2

 
$
1,765.7

 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2013 (In millions)
U.S.
 
Europe(1)
 
Germany
 
Asia
 
Other
 
Total
Product revenues from external customers
$
3,581.0

 
$
1,170.2

 
$
417.7

 
$
93.2

 
$
280.2

 
$
5,542.3

Revenues from unconsolidated joint business
$
1,087.3

 
$
1.6

 
$

 
$
3.2

 
$
33.9

 
$
1,126.0

Other revenues from external customers
$
193.5

 
$
26.1

 
$
1.2

 
$
43.1

 
$

 
$
263.9

Long-lived assets
$
984.4

 
$
758.3

 
$
2.5

 
$
2.1

 
$
3.3

 
$
1,750.7

 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012 (In millions)
U.S.
 
Europe(1)
 
Germany
 
Asia
 
Other
 
Total
Product revenues from external customers
$
2,176.8

 
$
1,216.2

 
$
409.2

 
$
93.2

 
$
270.7

 
$
4,166.1

Revenues from unconsolidated joint business
$
1,033.3

 
$
14.3

 
$

 
$
27.5

 
$
62.8

 
$
1,137.9

Other revenues from external customers
$
170.2

 
$
27.9

 
$
1.1

 
$
13.3

 
$

 
$
212.5

Long-lived assets
$
996.6

 
$
738.6

 
$
1.9

 
$
2.9

 
$
2.2

 
$
1,742.2